A vérplazma emelkedett lipidszintje a cardiovascularis betegségek kialakulásának egyik legfőbb kockázati tényezője, amelyet elsődleges halálokként tartanak számon. Az apolipoprotein E a lipidek szállításában vesz részt a vérben, ezért polimorfizmusai befolyásolják a plazma lipidösszetételét. Az apolipoprotein E génjének három leggyakoribb alléljai az e2, az e3 és az e4. A két nem vad típusú allél, az e2 és e4 közül az utóbbi számos vizsgálat eredménye szerint szerepet játszik a szív-ér rendszeri betegségek, valamint az Alzheimer-kór kialakulásában. Az e2/e2 homozigóta genotípust a 3-as típusú hyperlipoproteinaemia egyik előidézőjeként említik egyes tanulmányok. Mivel az apolipoprotein E nemcsak a lipidanyagcsere útján, hanem más biokémiai útvonalakon is befolyásolhatja a cardiovascularis betegségek manifesztációját, így kiemelkedő fontosságú lehet ezen anyagcsereutak molekuláris hátterének felderítése. Orv. Hetil., 2012, 153, 2070–2076.
Dominiczak, M. H., Caslake, M. J.: Apolipoproteins: metabolic role and clinical biochemistry applications. Ann. Clin. Biochem., 2011, 48, 498–515.
Caslake M. J. , 'Apolipoproteins: metabolic role and clinical biochemistry applications ' (2011 ) 48 Ann. Clin. Biochem. : 498 -515 .
Oram, J. F., Yokoyama, S.: Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res., 1996, 37, 2473–2491.
Yokoyama S. , 'Apolipoprotein-mediated removal of cellular cholesterol and phospholipids ' (1996 ) 37 J. Lipid Res. : 2473 -2491 .
Dart, A. M., Chin-Dusting, J. P.: Lipids and the endothelium. Cardiovasc. Res., 1999, 43, 308–322.
Chin-Dusting J. P. , 'Lipids and the endothelium ' (1999 ) 43 Cardiovasc. Res. : 308 -322 .
Vance, D. E.: Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr. Opin. Lipidol., 2008, 19, 229–234.
Vance D. E. , 'Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis ' (2008 ) 19 Curr. Opin. Lipidol. : 229 -234 .
Bhatnagar, D., Durrington, P. N.: Clinical value of apolipoprotein measurement. Ann. Clin. Biochem., 1991, 28, 427–437.
Durrington P. N. , 'Clinical value of apolipoprotein measurement ' (1991 ) 28 Ann. Clin. Biochem. : 427 -437 .
Dedoussis, G. V.: Apolipoprotein polymorphisms and familial hypercholesterolemia. Pharmacogenomics, 2007, 8, 1179–1189.
Dedoussis G. V. , 'Apolipoprotein polymorphisms and familial hypercholesterolemia ' (2007 ) 8 Pharmacogenomics : 1179 -1189 .
Nofer, J. R., Brodde, M. F., Kehrel, B. E.: High-density lipoproteins, platelets and the pathogenesis of atherosclerosis. Clin. Exp. Pharmacol. Physiol., 2010, 37, 726–735.
Kehrel B. E. , 'High-density lipoproteins, platelets and the pathogenesis of atherosclerosis ' (2010 ) 37 Clin. Exp. Pharmacol. Physiol. : 726 -735 .
Fisher, E. A.: The degradation of apolipoprotein B100: Multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways. Biochim. Biophys. Acta, 2012, 1821, 778–781.
Fisher E. A. , 'The degradation of apolipoprotein B100: Multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways ' (2012 ) 1821 Biochim. Biophys. Acta : 778 -781 .
Samson, S., Mundkur, L., Kakkar, V. V.: Immune response to lipoproteins in atherosclerosis. Cholesterol, 2012, 2012, 571846.
Kakkar V. V. , 'Immune response to lipoproteins in atherosclerosis ' (2012 ) 2012 Cholesterol : 571846 -.
Stancu, C. S., Toma, L., Sima, A. V.: Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis. Cell Tissue Res., 2012, 349, 433–446.
Sima A. V. , 'Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis ' (2012 ) 349 Cell Tissue Res. : 433 -446 .
Iwata, H., Nagai, R.: Novel immune signals and atherosclerosis. Curr. Atheroscler. Rep., 2012, 14, 484–490.
Nagai R. , 'Novel immune signals and atherosclerosis ' (2012 ) 14 Curr. Atheroscler. Rep. : 484 -490 .
Itabe, H.: Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis. J. Clin. Biochem. Nutr., 2012, 51, 1–8.
Itabe H. , 'Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis ' (2012 ) 51 J. Clin. Biochem. Nutr. : 1 -8 .
Mahley, R. W.: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 1988, 240, 622–630.
Mahley R. W. , 'Apolipoprotein E: cholesterol transport protein with expanding role in cell biology ' (1988 ) 240 Science : 622 -630 .
Frank, A., Diez-Tejedor, E., Bullido, M. J., et al.: APOE genotype in cerebrovascular disease and vascular dementia. J. Neurol. Sci., 2002, 203–204, 173–176.
Bullido M. J. , 'APOE genotype in cerebrovascular disease and vascular dementia ' (2002 ) 203–204 J. Neurol. Sci. : 173 -176 .
Paik, Y. K., Chang, D. J., Reardon, C. A., et al.: Nucleotide sequence and structure of the human apolipoprotein E gene. Proc. Natl. Acad. Sci. USA, 1985, 82, 3445–3449.
Reardon C. A. , 'Nucleotide sequence and structure of the human apolipoprotein E gene ' (1985 ) 82 Proc. Natl. Acad. Sci. USA : 3445 -3449 .
Weisgraber, K. H., Rall, S. C. Jr., Mahley, R. W.: Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem., 1981, 256, 9077–9083.
Mahley R. W. , 'Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms ' (1981 ) 256 J. Biol. Chem. : 9077 -9083 .
Hauser, P. S., Narayanaswami, V., Ryan, R. O.: Apolipoprotein E: from lipid transport to neurobiology. Prog. Lipid Res., 2011, 50, 62–74.
Ryan R. O. , 'Apolipoprotein E: from lipid transport to neurobiology ' (2011 ) 50 Prog. Lipid Res. : 62 -74 .
Eichner, J. E., Dunn, S. T., Perveen, G., et al.: Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol., 2002, 155, 487–495.
Perveen G. , 'Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review ' (2002 ) 155 Am. J. Epidemiol. : 487 -495 .
Singh, P. P., Singh, M., Mastana, S. S.: APOE distribution in world populations with new data from India and the UK. Ann. Hum. Biol., 2006, 33, 279–308.
Mastana S. S. , 'APOE distribution in world populations with new data from India and the UK ' (2006 ) 33 Ann. Hum. Biol. : 279 -308 .
Weisgraber, K. H.: Apolipoprotein E: structure-function relationships. Adv. Protein Chem., 1994, 45, 249–302.
Weisgraber K. H. , 'Apolipoprotein E: structure-function relationships ' (1994 ) 45 Adv. Protein Chem. : 249 -302 .
Yamamura, T., Dong, L. M., Yamamoto, A.: Characterization of apolipoprotein E7 (Glu244→Lys, Glu245→Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis. J. Lipid Res., 1999, 40, 253–259.
Yamamoto A. , 'Characterization of apolipoprotein E7 (Glu244→Lys, Glu245→Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis ' (1999 ) 40 J. Lipid Res. : 253 -259 .
Cautero, N., Di Benedetto, F., De Ruvo, N., et al.: Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report. Transplant. Proc., 2010, 42, 1349–1351.
Ruvo N. , 'Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report ' (2010 ) 42 Transplant. Proc. : 1349 -1351 .
Mahley, R. W., Rall, S. C. Jr.: Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet., 2000, 1, 507–537.
Rall S. C. , 'Apolipoprotein E: far more than a lipid transport protein ' (2000 ) 1 Annu. Rev. Genomics Hum. Genet. : 507 -537 .
Ashavaid, T. F., Todur, S. P., Nair, K. G.: Apolipoprotein E polymorphism and coronary heart disease. J. Assoc. Physicians India, 2003, 51, 784–788.
Nair K. G. , 'Apolipoprotein E polymorphism and coronary heart disease ' (2003 ) 51 J. Assoc. Physicians India : 784 -788 .
Mahley, R. W., Palaoğlu, K. E., Atak, Z., et al.: Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J. Lipid Res., 1995, 36, 839–859.
Atak Z. , 'Turkish Heart Study: lipids, lipoproteins, and apolipoproteins ' (1995 ) 36 J. Lipid Res. : 839 -859 .
Kesäniemi, Y. A., Ehnholm, C., Miettinen, T. A.: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J. Clin. Invest., 1987, 80, 578–581.
Miettinen T. A. , 'Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype ' (1987 ) 80 J. Clin. Invest. : 578 -581 .
Weintraub, M. S., Eisenberg, S., Breslow, J. L.: Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest., 1987, 80, 1571–1577.
Breslow J. L. , 'Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E ' (1987 ) 80 J. Clin. Invest. : 1571 -1577 .
Siest, G., Pillot, T., Régis-Bailly, A., et al.: Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin. Chem., 1995, 41, 1068–1086.
Régis-Bailly A. , 'Apolipoprotein E: an important gene and protein to follow in laboratory medicine ' (1995 ) 41 Clin. Chem. : 1068 -1086 .
Song, Y., Stampfer, M. J., Liu, S.: Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med., 2004, 141, 137–147.
Liu S. , 'Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease ' (2004 ) 141 Ann. Intern. Med. : 137 -147 .
Kulminski, A. M., Culminskaya, I., Ukraintseva, S. V.: Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell, 2011, 10, 533–541.
Ukraintseva S. V. , 'Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan ' (2011 ) 10 Aging Cell : 533 -541 .
Muendlein, A., Saely, C. H., Marte, T., et al.: Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with coronary artery disease. Atherosclerosis, 2008, 199, 179–186.
Marte T. , 'Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with coronary artery disease ' (2008 ) 199 Atherosclerosis : 179 -186 .
Heide, S., Manfred, K., Gläser, C., et al.: Apolipoprotein E (apoE) polymorphism: a risk factor for fatal coronary sclerosis? Forensic Sci. Int., 2009, 192, 62–66.
Gläser C. , 'Apolipoprotein E (apoE) polymorphism: a risk factor for fatal coronary sclerosis? ' (2009 ) 192 Forensic Sci. Int. : 62 -66 .
Li, S. S., Yang, J., Li, L. S., et al.: Apolipoprotein E polymorphism and the characteristics of diseased vessels in male Chinese patients with angiographic coronary artery disease: a case-case study. Clin. Cardiol., 2010, 33, E30–E34.
Li L. S. , 'Apolipoprotein E polymorphism and the characteristics of diseased vessels in male Chinese patients with angiographic coronary artery disease: a case-case study ' (2010 ) 33 Clin. Cardiol. : E30 -E34 .
Poledne, R., Hubáček, J. A., Staněk, V., et al.: Why we are not able to find the coronary heart disease gene – apoE as an example. Folia Biol. (Praha), 2010, 56, 218–222.
Staněk V. , 'Why we are not able to find the coronary heart disease gene – apoE as an example ' (2010 ) 56 Folia Biol. (Praha) : 218 -222 .
Gamboa, R., Huesca-Gómez, C., Pérez-Méndez, O., et al.: Apolipoprotein E polymorphisms in Mexican patients with coronary artery disease. Clin. Chem. Lab. Med., 2008, 46, 481–485.
Pérez-Méndez O. , 'Apolipoprotein E polymorphisms in Mexican patients with coronary artery disease ' (2008 ) 46 Clin. Chem. Lab. Med. : 481 -485 .
Artieda, M., Gañán, A., Cenarro, A., et al.: Association and linkage disequilibrium analyses of APOE polymorphisms in atherosclerosis. Dis. Markers, 2008, 24, 65–72.
Cenarro A. , 'Association and linkage disequilibrium analyses of APOE polymorphisms in atherosclerosis ' (2008 ) 24 Dis. Markers : 65 -72 .
Paternoster, L., Martinez-Gonzalez, N. A., Charleton, R., et al.: Genetic effects on carotid intima-media thickness: systematic assessment and meta-analyses of candidate gene polymorphisms studied in more than 5000 subjects. Circ. Cardiovasc. Genet., 2010, 3, 15–21.
Charleton R. , 'Genetic effects on carotid intima-media thickness: systematic assessment and meta-analyses of candidate gene polymorphisms studied in more than 5000 subjects ' (2010 ) 3 Circ. Cardiovasc. Genet. : 15 -21 .
Ferreira, D. C., Costa, T. F., Aguiar, S. L., et al.: Association of apoliprotein E polymorphisms and metabolic syndrome in subjects with extreme obesity. Clin. Chim. Acta, 2011, 412, 1559–1562.
Aguiar S. L. , 'Association of apoliprotein E polymorphisms and metabolic syndrome in subjects with extreme obesity ' (2011 ) 412 Clin. Chim. Acta : 1559 -1562 .
Wilson, P. W., Schaefer, E. J., Larson, M. G., et al.: Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler. Thromb. Vasc. Biol., 1996, 16, 1250–1255.
Larson M. G. , 'Apolipoprotein E alleles and risk of coronary disease. A meta-analysis ' (1996 ) 16 Arterioscler. Thromb. Vasc. Biol. : 1250 -1255 .
Corder, E. H., Saunders, A. M., Strittmatter, W. J., et al.: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 1993, 261, 921–923.
Strittmatter W. J. , 'Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families ' (1993 ) 261 Science : 921 -923 .
Bretsky, P., Guralnik, J. M., Launer, L., et al.: The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 2003, 60, 1077–1081.
Launer L. , 'The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging ' (2003 ) 60 Neurology : 1077 -1081 .
Chaudhary, R., Likidlilid, A., Peerapatdit, T., et al.: Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc. Diabetol., 2012, 11, 36.
Peerapatdit T. , 'Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease ' (2012 ) 11 Cardiovasc. Diabetol. : 36 -.
Jordan, B. D., Relkin, N. R., Ravdin, L. D., et al.: Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA, 1997, 278, 136–140.
Ravdin L. D. , 'Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing ' (1997 ) 278 JAMA : 136 -140 .
Grammer, T. B., Hoffmann, M. M., Renner, W., et al.: Apolipoprotein E genotypes, circulating C-reactive protein and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis, 2011, 215, 487–493.
Renner W. , 'Apolipoprotein E genotypes, circulating C-reactive protein and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study ' (2011 ) 215 Atherosclerosis : 487 -493 .
Matera, M. G., Sancarlo, D., Panza, F., et al.: Apolipoprotein E-related all-cause mortality in hospitalized elderly patients. Age (Dordr), 2010, 32, 411–420.
Panza F. , 'Apolipoprotein E-related all-cause mortality in hospitalized elderly patients ' (2010 ) 32 Age (Dordr) : 411 -420 .
Ken-Dror, G., Talmud, P. J., Humphries, S. E., et al.: APOE/C1/C4/C2 gene cluster genotypes, haplotypes and lipid levels in prospective coronary heart disease risk among UK healthy men. Mol. Med., 2010, 16, 389–399.
Humphries S. E. , 'APOE/C1/C4/C2 gene cluster genotypes, haplotypes and lipid levels in prospective coronary heart disease risk among UK healthy men ' (2010 ) 16 Mol. Med. : 389 -399 .
Kulminski, A. M., Ukraintseva, S. V., Arbeev, K. G., et al.: Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men. J. Am. Geriatr. Soc., 2008, 56, 478–483.
Arbeev K. G. , 'Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men ' (2008 ) 56 J. Am. Geriatr. Soc. : 478 -483 .
Fuzikawa, A. K., Peixoto, S. V., Taufer, M., et al.: Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS). Braz. J. Med. Biol. Res., 2008, 41, 89–94.
Taufer M. , 'Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS) ' (2008 ) 41 Braz. J. Med. Biol. Res. : 89 -94 .
Minihane, A. M., Jofre-Monseny, L., Olano-Martin, E., et al.: ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc. Nutr. Soc., 2007, 66, 183–197.
Olano-Martin E. , 'ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation ' (2007 ) 66 Proc. Nutr. Soc. : 183 -197 .
Swertfeger, D. K., Hui, D. Y.: Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation. J. Biol. Chem., 2001, 276, 25043–25048.
Hui D. Y. , 'Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation ' (2001 ) 276 J. Biol. Chem. : 25043 -25048 .
Stannard, A. K., Riddell, D. R., Sacre, S. M., et al.: Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J. Biol. Chem., 2001, 276, 46011–46016.
Sacre S. M. , 'Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells ' (2001 ) 276 J. Biol. Chem. : 46011 -46016 .
Hayek, T., Oiknine, J., Brook, J. G., et al.: Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem. Biophys. Res. Commun., 1994, 201, 1567–1574.
Brook J. G. , 'Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice ' (1994 ) 201 Biochem. Biophys. Res. Commun. : 1567 -1574 .
Lynch, J. R., Tang, W., Wang, H., et al.: APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem., 2003, 278, 48529–48533.
Wang H. , 'APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response ' (2003 ) 278 J. Biol. Chem. : 48529 -48533 .
Zeleny, M., Swertfeger, D. K., Weisgraber, K. H., et al.: Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation. Biochemistry, 2002, 41, 11820–11823.
Weisgraber K. H. , 'Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation ' (2002 ) 41 Biochemistry : 11820 -11823 .
Jofre-Monseny, L., de Pascual-Teresa, S., Plonka, E., et al.: Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages. Br. J. Nutr., 2007, 97, 864–871.
Plonka E. , 'Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages ' (2007 ) 97 Br. J. Nutr. : 864 -871 .